Ovoca Bio (DUB:OVXA) FCF Margin % : 0.00% (As of Jun. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Ovoca Bio FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ovoca Bio's Free Cash Flow for the six months ended in Jun. 2023 was €-0.68 Mil. Ovoca Bio's Revenue for the six months ended in Jun. 2023 was €0.00 Mil. Therefore, Ovoca Bio's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

As of today, Ovoca Bio's current FCF Yield % is -205.15%.

The historical rank and industry rank for Ovoca Bio's FCF Margin % or its related term are showing as below:

DUB:OVXA's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -138.52
* Ranked among companies with meaningful FCF Margin % only.

Ovoca Bio FCF Margin % Historical Data

The historical data trend for Ovoca Bio's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovoca Bio FCF Margin % Chart

Ovoca Bio Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

Ovoca Bio Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Ovoca Bio's FCF Margin %

For the Biotechnology subindustry, Ovoca Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ovoca Bio's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ovoca Bio's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ovoca Bio's FCF Margin % falls into.

Ovoca Bio FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ovoca Bio's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-5.206	/	0
	=	%

Ovoca Bio's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-0.68	/	0
	=	%

Ovoca Bio FCF Margin % Related Terms

Thank you for viewing the detailed overview of Ovoca Bio's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovoca Bio (DUB:OVXA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (DUB:OVXA) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

OVB.GB:UK OVB:UK OVXA:Germany

Address

17 Pembroke Street Upper, Dublin, IRL, D02 AT22

Website

https://www.ovocabio.com

Ovoca Bio PLC is a life science investment company. The company is engaged in investing in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. The group has two business segments, bio-pharmaceutical and investment, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX - Libicore - a novel synthetic peptide, administrated through a nasal spray.

Ovoca Bio (DUB:OVXA) Headlines

No Headlines